Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$234M |
| 2 |
eBay
EBAY
|
+$223M |
| 3 |
Walt Disney
DIS
|
+$189M |
| 4 |
Humana
HUM
|
+$184M |
| 5 |
DXC Technology
DXC
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$236M |
| 2 |
Citizens Financial Group
CFG
|
+$157M |
| 3 |
Applied Materials
AMAT
|
+$156M |
| 4 |
Huntsman Corp
HUN
|
+$154M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.97% |
| 2 | Technology | 16.56% |
| 3 | Industrials | 15.08% |
| 4 | Healthcare | 12.53% |
| 5 | Consumer Discretionary | 12.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Super Micro Computer
SMCI
$22.8B
| $1.81M | ﹤0.01% |
735,150
+249,220
| +51% | +$609K |
|
|
CLR
1427
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $1.81M | ﹤0.01% |
56,019
-48,973
| -47% | -$1.94M |
|
|
NATI
1428
DELISTED
National Instruments Corp
NATI
| $1.8M | ﹤0.01% |
44,871
+361
| +0.8% | +$13.1K |
|
|
ARI
1429
Apollo Commercial Real Estate
ARI
$883M
| $1.8M | ﹤0.01% |
97,253
| – | – |
|
1430
Stewart Information Services
STC
$2.13B
| $1.8M | ﹤0.01% |
39,701
+18,957
| +91% | +$854K |
|
1431
Vulcan Materials
VMC
$35.8B
| $1.8M | ﹤0.01% |
14,211
-6,956
| -33% | -$873K |
|
|
TRUE
1432
DELISTED
TrueCar
TRUE
| $1.79M | ﹤0.01% |
89,606
+40,581
| +83% | +$700K |
|
|
CMO
1433
DELISTED
Capstead Mortgage Corp.
CMO
| $1.78M | ﹤0.01% |
171,147
| – | – |
|
1434
Ingles Markets
IMKTA
$1.62B
| $1.78M | ﹤0.01% |
53,514
+16,638
| +45% | +$661K |
|
1435
Sarepta Therapeutics
SRPT
$1.92B
| $1.78M | ﹤0.01% |
52,868
+501
| +1% | +$16.3K |
|
1436
Brink's
BCO
$4.65B
| $1.78M | ﹤0.01% |
26,509
-2,874
| -10% | -$177K |
|
1437
Lamar Advertising Co
LAMR
$15.5B
| $1.78M | ﹤0.01% |
24,142
-3,433
| -12% | -$246K |
|
|
ELLI
1438
DELISTED
Ellie Mae Inc
ELLI
| $1.76M | ﹤0.01% |
16,049
-495
| -3% | -$53.6K |
|
1439
Resources Connection
RGP
$147M
| $1.76M | ﹤0.01% |
+128,534
| New | +$1.75M |
|
|
BV
1440
DELISTED
Bazaarvoice, Inc.
BV
| $1.76M | ﹤0.01% |
355,361
+151,737
| +75% | +$700K |
|
|
MNTA
1441
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.76M | ﹤0.01% |
104,012
+63,618
| +157% | +$968K |
|
|
GHL
1442
DELISTED
Greenhill & Co., Inc.
GHL
| $1.75M | ﹤0.01% |
87,309
+20,731
| +31% | +$485K |
|
|
FARO
1443
DELISTED
Faro Technologies
FARO
| $1.75M | ﹤0.01% |
46,395
-45,645
| -50% | -$1.62M |
|
|
BFS
1444
Saul Centers
BFS
$844M
| $1.75M | ﹤0.01% |
30,205
-7,881
| -21% | -$472K |
|
|
TAHO
1445
DELISTED
Tahoe Resources Inc
TAHO
| $1.74M | ﹤0.01% |
201,519
-16,700
| -8% | -$145K |
|
1446
IPG Photonics
IPGP
$3.01B
| $1.73M | ﹤0.01% |
11,949
+963
| +9% | +$129K |
|
1447
Energizer
ENR
$1.47B
| $1.73M | ﹤0.01% |
35,982
-38,384
| -52% | -$2.09M |
|
1448
Motorola Solutions
MSI
$79.7B
| $1.73M | ﹤0.01% |
19,894
+2,306
| +13% | +$196K |
|
|
ATRI
1449
DELISTED
Atrion Corp
ATRI
| $1.73M | ﹤0.01% |
2,683
+129
| +5% | +$69.4K |
|
|
DENN
1450
DELISTED
Denny's
DENN
| $1.72M | ﹤0.01% |
146,414
-14,542
| -9% | -$174K |
|
Similar funds
Cliff Asness's Q2 2017 Portfolio in Review
As of Q2 2017, Cliff Asness held 2,306 positions worth $75.6B, up 0.44% from $75.2B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
Cliff Asness's Q2 2017 filing shows 139 new, 928 increased, 1,013 reduced and 118 closed positions. Its largest new stake was DXC Technology: 2,594,054 shares worth $172M. The largest sale was Wells Fargo, an estimated $236M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
- Cliff Asness's largest Q2 2017 buy was DXC Technology: 2,594,054 shares worth $172M.
- Cliff Asness added most to Gilead Sciences in Q2 2017, an estimated $234M increase.
- Cliff Asness's biggest Q2 2017 reduction was Wells Fargo, cutting an estimated $236M.
- Cliff Asness fully exited Computer Sciences in Q2 2017, selling an estimated $77.8M.
- Cliff Asness's ten largest holdings make up 9.2% of its $75.6B portfolio in Q2 2017.
- Cliff Asness opened 139 new positions and closed 118 in Q2 2017.
- Cliff Asness's portfolio value rose 0.44% quarter-over-quarter to $75.6B.
Based on AQR Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.